Verastem just pulled the plug on its big lung cancer trial (RAMP 203) after some tough competition and higher expectations from new KRAS G12C drugs. Instead, they’re betting big on their new pill, VS-7375, which is showing some wild response rates in early tests. Basically, they’re shifting gears to chase bigger wins in the cancer treatment race. Pharma drama, anyone? #Health #BodyHealth #biotech